ETFS

BioRestorative Therapies (NASDAQ:BRTX – Get Free Report) and Akari Therapeutics (NASDAQ:AKTX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Insider and Institutional Ownership 6.9% of BioRestorative

Three Bridge Wealth Advisors LLC lowered its stake in The Walt Disney Company (NYSE:DIS – Free Report) by 7.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 18,205 shares of the entertainment giant’s stock after selling 1,512 shares during the quarter. Walt Disney accounts for about

Tri Pointe Homes (NYSE:TPH – Get Free Report) and Bellway (OTCMKTS:BLWYF – Get Free Report) are both consumer cyclical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability. Profitability This table compares Tri Pointe Homes

Capital Investment Advisory Services LLC cut its holdings in shares of Costco Wholesale Co. (NASDAQ:COST – Free Report) by 3.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,273 shares of the retailer’s stock after selling 167 shares during the

Fortune Brands Innovations (NYSE:FBIN – Free Report) had its price target decreased by Jefferies Financial Group from $90.00 to $88.00 in a report published on Thursday, FlyOnTheWall reports. A number of other analysts have also recently commented on FBIN. Truist Financial boosted their target price on shares of Fortune Brands Innovations from $75.00 to $90.00

Folger Nolan Fleming Douglas Capital Management Inc. decreased its stake in Target Co. (NYSE:TGT – Free Report) by 1.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,345 shares of the retailer’s stock after selling 100 shares during

Stagwell Inc. (NASDAQ:STGW – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among

GAM Holding AG cut its stake in Vanguard S&P 500 ETF (NYSEARCA:VOO – Free Report) by 28.4% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 40,452 shares of the company’s stock after selling 16,032 shares during the quarter. Vanguard S&P 500 ETF comprises

bleuacacia (NASDAQ:BLEU – Get Free Report) is one of 680 public companies in the “Holding & other investment offices” industry, but how does it weigh in compared to its competitors? We will compare bleuacacia to related companies based on the strength of its earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership. Volatility &

Shulman DeMeo Asset Management LLC cut its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 5.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,098 shares of the company’s stock after selling 111 shares during the quarter.

Plancorp LLC increased its position in Vanguard Small-Cap ETF (NYSEARCA:VB – Free Report) by 2.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,175 shares of the company’s stock after acquiring an additional 58 shares during the quarter. Plancorp LLC’s holdings in

PubMatic, Inc. (NASDAQ:PUBM – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven analysts that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target among brokerages

Silverlake Wealth Management LLC lifted its holdings in AT&T Inc. (NYSE:T – Free Report) by 15.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 77,379 shares of the technology company’s stock after buying an additional 10,445 shares during the quarter. Silverlake Wealth Management LLC’s

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has been given an average rating of “Moderate Buy” by the nine analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price

Fifth Third Wealth Advisors LLC lifted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 232.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,900 shares of the company’s stock after purchasing an additional 2,028 shares during the period.

Provence Wealth Management Group boosted its holdings in shares of Broadcom Inc. (NASDAQ:AVGO – Free Report) by 11.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,549 shares of the semiconductor manufacturer’s stock after acquiring an additional 165 shares

Breakwater Capital Group boosted its stake in iShares MSCI EAFE Growth ETF (BATS:EFG – Free Report) by 12.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,899 shares of the company’s stock after purchasing an additional 2,253 shares during the quarter. Breakwater Capital Group’s

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price lowered by Jefferies Financial Group from $47.00 to $45.00 in a research note issued to investors on Monday morning, Marketbeat Ratings reports. The brokerage currently has a buy rating on the medical device company’s stock. Other analysts have also recently issued reports about the

Values Added Financial LLC acquired a new position in Accenture plc (NYSE:ACN – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 730 shares of the information technology services provider’s stock, valued at approximately $225,000. A number of other